2,833
Views
63
CrossRef citations to date
0
Altmetric
Review

Plant glycans: friend or foe in vaccine development?

&
Pages 835-842 | Published online: 09 Jan 2014

References

  • Fenner F, Henderson DA, Arita I, JeZek Z, Ladnyi ID. Smallpox and its eradication. World Health Organization, Geneva, Switzerland (1988).
  • Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA89(24), 11745–11749 (1992).
  • Yusibov V, Rabindran S. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines7(8), 1173–1183 (2008).
  • Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol. J.8, 1–18 (2010).
  • Jin C, Altmann F, Strasser R et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology18(3), 235–241 (2008).
  • Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine23(15), 1770–1778 (2005).
  • van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int. Arch. Allergy Immunol.129(3), 189–197 (2002).
  • Fiedler K, Simons K. The role of N-glycans in the secretory pathway. Cell81(3), 309–312 (1995).
  • Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem.54, 631–664 (1985).
  • Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell126(5), 855–867 (2006).
  • Helenius J, Ng DT, Marolda CL, Walter P, Valvano MA, Aebi M. Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein. Nature415(6870), 447–450 (2002).
  • Snider MD, Sultzman LA, Robbins PW. Transmembrane location of oligosaccharide-lipid synthesis in microsomal vesicles. Cell21(2), 385–392 (1980).
  • Henquet M, Lehle L, Schreuder M et al. Identification of the gene encoding the α1,3-mannosyltransferase (ALG3) in Arabidopsis and characterization of downstream N-glycan processing. Plant Cell20(6), 1652–1664 (2008).
  • Jin H, Yan Z, Nam KH, Li J. Allele-specific suppression of a defective brassinosteroid receptor reveals a physiological role of UGGT in ER quality control. Mol. Cell26(6), 821–830 (2007).
  • Lederkremer GZ. Glycoprotein folding, quality control and ER-associated degradation. Curr. Opin. Struct. Biol.19(5), 515–523 (2009).
  • Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Laine AC, Gomord V, Faye L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol.38(1–2), 31–48 (1998).
  • Vitale A, Chrispeels MJ. Transient N-acetylglucosamine in the biosynthesis of phytohemagglutinin: attachment in the Golgi apparatus and removal in protein bodies. J. Cell Biol.99(1 Pt 1), 133–140 (1984).
  • Fitchette-Lainè A-C, Gomord V, Cabanes M et al.N-glycans harboring the Lewis A epitope are expressed at the surface of plant cells. Plant J.12(6), 1411–1417 (1997).
  • Bakker H, Schijlen E, de Vries T et al. Plant members of the α1,3/4-fucosyltransferase gene family encode an α 1,4-fucosyltransferase, potentially involved in Lewis(A) biosynthesis, and two core α 1,3-fucosyltransferases. FEBS Lett.507(3), 307–312 (2001).
  • Elbers IJ, Stoopen GM, Bakker H et al. Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves. Plant Physiol.126(3), 1314–1322 (2001).
  • Sturm A, Van Kuik JA, Vliegenthart JF, Chrispeels MJ. Structure, position, and biosynthesis of the high mannose and the complex oligosaccharide side chains of the bean storage protein phaseolin. J. Biol. Chem.262(28), 13392–13403 (1987).
  • Mari A. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int. Arch. Allergy Immunol.129(4), 286–295 (2002).
  • Foetisch K, Westphal S, Lauer I et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. J. Allergy Clin. Immunol.111(4), 889–896 (2003).
  • Bublin M, Radauer C, Wilson IB et al. Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. FASEB J.17(12), 1697–1699 (2003).
  • van Ree R. Clinical importance of cross-reactivity in food allergy. Curr. Opin. Allergy Clin. Immunol.4(3), 235–240 (2004).
  • Bardor M, Faveeuw C, Fitchette A-C et al. Immunoreactivity in mammals of two typical plant glyco-epitopes, core α1,3-fucose and core xylose. Glycobiology13(6), 427–434 (2003).
  • Faye L, Chrispeels MJ. Common antigenic determinants in the glycoproteins of plants, molluscs and insects. Glycoconjugate J.5(3), 245–256 (1988).
  • Chargelegue D, Vine ND, van Dolleweerd CJ, Drake PM, Ma JK. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res.9(3), 187–194 (2000).
  • Ma JK, Hikmat BY, Wycoff K et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med.4(5), 601–606 (1998).
  • Mari A, Ooievaar-de Heer P, Scala E et al. Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy63(7), 891–896 (2008).
  • Huether CM, Lienhart O, Baur A et al. Glyco-engineering of moss lacking plant-specific sugar residues. Plant Biol. (Stuttg.)7(3), 292–299 (2005).
  • Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J.5(5), 657–663 (2007).
  • Strasser R, Stadlmann J, Schahs M et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J.6(4), 392–402 (2008).
  • Sourrouille C, Marquet-Blouin E, D’Aoust MA et al. Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J.6(7), 702–721 (2008).
  • Cox KM, Sterling JD, Regan JT et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotech.24(12), 1591–1597 (2006).
  • Bakker H, Rouwendal GJ, Karnoup AS et al. An antibody produced in tobacco expressing a hybrid β1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl Acad. Sci. USA103(20), 7577–7582 (2006).
  • Palacpac NQ, Yoshida S, Sakai H et al. Stable expression of human β1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl Acad. Sci. USA96(8), 4692–4697 (1999).
  • Bakker H, Bardor M, Molthoff JW et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl Acad. Sci. USA98(5), 2899–2904 (2001).
  • Strasser R, Castilho A, Stadlmann J et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous β1,4-galactosylated N-glycan profile. J. Biol. Chem.284(31), 20479–20485 (2009).
  • Castilho A, Strasser R, Stadlmann J et al.In planta protein sialylation through over-expression of the respective mammalian pathway. J. Biol. Chem.285(21), 15923–15930 (2010).
  • Rouwendal GJ, Florack DE, Hesselink T, Cordewener JH, Helsper JP, Bosch D. Synthesis of Lewis X epitopes on plant N-glycans. Carbohydr. Res.344(12), 1487–1493 (2009).
  • Rouwendal GJ, Wuhrer M, Florack DE et al. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology17(3), 334–344 (2007).
  • Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol.1(2), 135–145 (2001).
  • Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and langerhans cells. Nat. Rev. Immunol.2(2), 77–84 (2002).
  • Geijtenbeek TBH, van Vliet SJ, Engering A, ‘t Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Ann. Rev. Immunol.22(1), 33–54 (2004).
  • Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol.9(4), 361–368 (2008).
  • Burgdorf S, Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr. Opin. Immunol.20(1), 89–95 (2008).
  • Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Ann. Rev. Immunol.20(1), 621–667 (2002).
  • Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHC II pathway. Cell117(5), 677–687 (2004).
  • Petrovsky N. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine24(Suppl. 2), S26–S29 (2006).
  • Huang D-F, Tang Y-F, Nie S-P, Wan Y, Xie M-Y, Xie X-M. Effect of phenylethanoid glycosides and polysaccharides from the seed of Plantago asiatica L. on the maturation of murine bone marrow-derived dendritic cells. Eur. J. Pharmacol.620(1–3), 105–111 (2009).
  • Sun H-X, Wang H, Xu H-s, Ni Y. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine27(30), 3984–3991 (2009).
  • Kensil C, Patel U, Lennick M, Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol.146(2), 431–437 (1991).
  • Singh SK, Stephani J, Schaefer M et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol. Immunol.47(2–3), 164–174 (2009).
  • Xie J, Guo L, Ruan Y et al. Laminarin-mediated targeting to dectin-1 enhances antigen-specific immune responses. Biochem. Biophys. Res. Comm.391(1), 958–962 (2010).
  • Ahlers JD, Belyakov IM. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol. Med.15(6), 263–274 (2009).
  • Shreffler WG, Castro RR, Kucuk ZY et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol.177(6), 3677–3685 (2006).
  • Kolarich D, Altmann F. N-glycan analysis by matrix-assisted laser desorption/ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen allergen Ole e 1. Anal. Biochem.285(1), 64–75 (2000).
  • Koppel EA, Ludwig IS, Appelmelk BJ, van Kooyk Y, Geijtenbeek TB. Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1. Immunobiology210(2–4), 195–201 (2005).
  • Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity26(5), 605–616 (2007).
  • Tacket CO. Plant-based oral vaccines: results of human trials. Curr. Top. Microbiol. Immunol.332, 103–117 (2009).
  • Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol.7(10), 790–802 (2007).
  • Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388(6640), 394–397 (1997).
  • Brown GD, Gordon S. A new receptor for β-glucans. Nature413(6851), 36–37 (2001).
  • Brooks SA. Strategies for analysis of the glycosylation of proteins: current status and future perspectives. Mol. Biotechnol.43(1), 76–88 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.